NCT01630083 2025-06-15
FAST
Astellas Pharma Inc
Phase 2 Completed
Clinical Trials
23 trialsNCT02287129 2023-11-28
MEMORI
Technical University of Munich
Phase 2 Completed
NCT00381706 2021-09-29
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT02128243 2021-03-26
MATEO
AIO-Studien-gGmbH
Phase 2 Completed
NCT02177552 2019-02-15
SEED
Rigshospitalet, Denmark
Phase 2 Unknown
NCT00215644 2018-11-02
MATRIX EG
Merck KGaA, Darmstadt, Germany
Phase 2 Completed
NCT01830270 2018-07-26
IPEC-GC
Centre Hospitalier Universitaire de Besancon
Phase 2 Terminated
NCT01234324 2018-01-23
NEOPECX
AIO-Studien-gGmbH
Phase 2 Completed
NCT02949258 2016-10-31
NCT-B4
Jinling Hospital, China
Phase 2 Unknown
NCT01123473 2016-10-12
Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
NCT00454636 2016-09-29
A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.
Hoffmann-La Roche
Phase 2 Completed
NCT01624025 2016-08-17
A Comparative Study of Salvage Treatment With Combination of Docetaxel and Epirubicin
Yonsei University
Phase 2 Completed
NCT00820053 2016-04-01
A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection
Eastern Hepatobiliary Surgery Hospital
Phase 2 Completed
NCT00737438 2016-02-03
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT01167738 2015-04-24
PACT-17
IRCCS San Raffaele
Phase 2 Terminated
NCT00375999 2014-03-03
Docetaxel and Epirubicin in Advanced Gastric Cancer
Yonsei University
Phase 2 Completed
NCT01964027 2013-10-17
SIEG
Anhui Medical University
Phase 2 Unknown
NCT00058487 2013-07-18
Epirubicin and Thalidomide in Treating Patients With Liver Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01710592 2013-01-10
ELECT
Cancer Trials Ireland
Phase 2 Completed
NCT00004873 2012-05-15
Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer
Swiss Cancer Institute
Phase 2 Completed
NCT00966706 2012-02-01
PACT-9
IRCCS San Raffaele
Phase 2 Completed
NCT00743964 2010-01-15
Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC)
Samsung Medical Center
Phase 2 Completed
NCT00220129 2009-12-16
Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus
Royal Marsden NHS Foundation Trust
Phase 2 Completed